Chr. Hansen and Novozymes have joined forces to create Novonesis, a leading biosolutions partner.
Novonesis means ‘a new beginning’. It's derived from the Greek word ‘genesis’. And that’s what we offer: a new beginning based on the power of biology.
The time for
biosolutions
is now.
A new beginning to better our world
The time for biosolutions is now
It’s time for change. For food systems that deliver more, healthier food. For better health from the beginning of life right through to old age. And for a healthy planet for generations to come. It’s time for the era of biosolutions.
Tiny but mighty enzymes, functional proteins and microbes enable change in all living things. We put that transformational power at the core of our biosolutions to help solve some of humanity’s biggest challenges.
Standing on the
shoulders of giants
We may be a new company, but we’ve got a big head start thanks to more than a century of experience from Chr. Hansen and the Novo Group. And we bring together 10,000 people with a passion for change.
Through our knowledge and dedication, we’ll help our customers and partners transform production and consumption.
There’s a biosolution for
(almost) everything
Higher crop yields from healthier soil and better animal welfare. Delicious food that stays fresher for longer. Cleaner, softer laundry. Lower emissions and less pollution. Better mental and physical health from birth to old age. These are just some of the many ways our biosolutions transform lives every day.
And we’re just getting started.
Ways to stay in touch
LinkedIn
Stay informed and share your thoughts with our Linkedin community.
News
Stay on top of what we're up to. Get our news straight to you.
The biosolutions bulletin
Everything you need to know about biosolutions, delivered monthly to your inbox.
Legacy Novozymes delivers solid last full-year results
Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% in 2023. This marks the last financial reporting from legacy Novozymes, and the new company, Novonesis, is already a reality.
Novozymes
Chr. Hansen